21 CFR 314.630

§ 314.630 Postmarketing safety reporting.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 314.630, § 314.630 Postmarketing safety reporting, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86402
Permanent ID: ys:prov:86402@1
SHA-256: 8b0dd15497a0ed2496cbcec655507ce3509aea4c62be692c9664764173c639d4

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

Drug products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting requirements applicable to all approved drug products, as provided in §§ 314.80 and 314.81.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.